In the CSF of ALS patients, SERPINC1 was identified as having a strong impact on the differentiation between fast and slow disease progression, with high SERPINC1 expression levels being associated with faster progression [64]. Here, SERPINC1 is linked to amyotrophic lateral sclerosis.